Collection of Circulating Biomarkers in Pancreatic Cancer

Description

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Conditions

Pancreas Cancer

Talk to us

Study Overview

On this page

Study Details

Study overview

This protocol will involve collection of blood samples from patients with a diagnosis of pancreatic adenocarcinoma for evaluation of circulating biomarkers.

Protocol to Permit Collection of Circulating Biomarkers in Pancreatic Cancer

Collection of Circulating Biomarkers in Pancreatic Cancer

Condition
Pancreas Cancer
Intervention / Treatment

-

Contacts and Locations

Philadelphia

Abramson Cancer Center at University of Pennsylvania, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * The subject must have a known or presumed diagnosis of pancreatic adenocarcinoma
  • * The subject must be a patient of the University of Pennsylvania
  • * The subject must be able to provide informed consent
  • * The subject must be 18 years of age or older

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Abramson Cancer Center at Penn Medicine,

Mark O'Hara, MD, PRINCIPAL_INVESTIGATOR, Abramson Cancer Center, University of Pennsylvania

Study Record Dates

2025-08-15